Irritable Bowel syndrome is a disease that affects the large intestine in most humans. It is very common between young children that occurs due to genetic reasons of wrongful diet plans. It includes symptoms as cramping, stomach aches or bloating. As common as this disease is, many different teams were focused on finding better alternative solutions that are more efficient to treat the disease.
A team of scientists led by PhD holder, James Versalovic who is the Department of Pathology & Immunology at Baylor College of Medicine and the Department of Pathology at Texas Children’s Hospital, Houston, TX, USA, were able to find a new method using Microbiome to find a more effective treatment. The study together with the results were published in the Journal Of Molecular Diagnostics.
The main goal obtained from the study was to be able to identify children who suffer from the disease easily to help them treat it quickly. This helps doctors treat efficiently and find better treatments according to the severity of the case.
Dr. James commented on his results saying, “This research highlights the importance of the microbiome-gut-brain axis and our understanding of chronic abdominal pain. Development of new disease classifiers based on microbiome data enables precision diagnostics to be developed for IBS and similar disorders. Although other studies have found differences in the gut microbiomes of patients with IBS, this study is the first to combine deep microbiome analysis with development of new diagnostic strategies.”